Key Points
Question
What is the efficacy and safety of tacrolimus vs intravenous cyclophosphamide (IVCY) as initial therapy for lupus nephritis (LN) among Chinese patients?
Findings
In this randomized clinical trial of 299 patients, the complete or partial kidney response rate was 83.0% with tacrolimus vs 75.0% with IVCY after 24 weeks of treatment, and tacrolimus was statistically noninferior to IVCY regarding response rate. The incidence and type of treatment-emergent adverse events reported were as expected in the patient population.
Meaning
These findings suggest that tacrolimus may be an alternative to IVCY as an initial therapy for LN.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.